Skip to main content
. Author manuscript; available in PMC: 2011 Mar 28.
Published in final edited form as: Early Interv Psychiatry. 2010 Aug;4(3):220–226. doi: 10.1111/j.1751-7893.2010.00183.x

Table 3.

Treatment History by Site and Year of Entry into the Study

Baseline Lifetime
Psychotropic
Medication
(N=350)		 Psychosocial
Treatment
(N=313)		 Psychotropic
Medication
(N=358)		 Psychosocial
Treatment
(N=313)
Site
    UNC (N=51) 54.9%** (N=48) 39.6%** (N=51) 74.5%** (N=48) 66.7%**
    Emory (N=9) 66.7% (N=8) 50.0% (N=9) 66.7% (N=8) 87.5%
    LIJ (N=44) 43.2% (N=44) 36.4% (N=44) 72.7% (N=44) 81.8%
    Toronto (N=34) 26.5% (N=35) 48.6% (N=39) 46.2% (N=36) 72.2%
    UCLA (N=34) 67.6% - (N=36) 77.8% -
    UCSD (N=59) 57.6% (N=57) 38.6% (N=59) 72.9% (N=55) 72.7%
    Yale (N=119) 21.0% (N=121) 77.7% (N=120) 41.7% (N=122) 95.1%
Year
    1998 (N=17) 0%** (N=17) 64.7% (N=18) 33.3%* (N=17) 94.1%
    1999 (N=25) 16.0% (N=26) 57.7% (N=25) 36.0% (N=26) 88.5%
    2000 (N=41) 24.4% (N=45) 62.2% (N=47) 55.3% (N=45) 80.0%
    2001 (N=43) 46.5% (N=39) 46.2% (N=43) 65.1% (N=38) 73.7%
    2002 (N=52) 51.9% (N=40) 55.0% (N=52) 69.2% (N=41) 78.0%
    2003 (N=59) 52.5% (N=49) 57.1% (N=59) 64.4% (N=49) 87.8%
    2004 (N=91) 46.2% (N=78) 49.5% (N=92) 65.2% (N=78) 79.5%
    2005 (N=22) 31.8% (N=19) 31.8% (N=22) 73.7% (N=19) 89.5%
**

p<0.01

*

p<0.05